Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjolijn J L Ligtenberg

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Current Opinion in Genetics & Development|April 13, 2010
Germline copy number variation and cancer riskRoland P Kuiper, Marjolijn J L Ligtenberg, Nicoline Hoogerbrugge, et al.
Familial Cancer|December 25, 2012
EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patientsMarjolijn J L Ligtenberg, Roland P Kuiper, Ad Geurts van Kessel, et al.
Virchows Archiv : an International Journal of Pathology|June 25, 2011
Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment schemeElisabeth Dequeker, Marjolijn J L Ligtenberg, Sara Vander Borght, et al.
International Journal of Molecular Sciences|November 24, 2020
Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes-Considerations for Future StudiesIris B A W Te Paske, Marjolijn J L Ligtenberg, Nicoline Hoogerbrugge, et al.
Cancer Letters|September 9, 2023
PARPing up the right tree; an overview of PARP inhibitors for metastatic castration-resistant prostate cancerPeter H J Slootbeek, Joanneke K Overbeek, Marjolijn J L Ligtenberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2010
A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspiratesOlga C J Schuurbiers, Monika G Looijen-Salamon, Marjolijn J L Ligtenberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2003
Dietary factors and microsatellite instability in sporadic colon carcinomasBrenda Diergaarde, Hanneke Braam, Goos N P van Muijen, et al.
Human Mutation|September 26, 2019
Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?Cleo Keppens, Véronique Tack, Kelly Dufraing, et al.
The Journal of Molecular Diagnostics : JMD|March 18, 2014
Higher quality of molecular testing, an unfulfilled priority: Results from external quality assessment for KRAS mutation testing in colorectal cancerLien Tembuyser, Marjolijn J L Ligtenberg, Nicola Normanno, et al.
Virchows Archiv : an International Journal of Pathology|November 18, 2015
RAS testing in metastatic colorectal cancer: advances in EuropeJ Han J M Van Krieken, Etienne Rouleau, Marjolijn J L Ligtenberg, et al.
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Current Opinion in Genetics & Development|April 13, 2010
Germline copy number variation and cancer riskRoland P Kuiper, Marjolijn J L Ligtenberg, Nicoline Hoogerbrugge, et al.
Familial Cancer|December 25, 2012
EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patientsMarjolijn J L Ligtenberg, Roland P Kuiper, Ad Geurts van Kessel, et al.
Virchows Archiv : an International Journal of Pathology|June 25, 2011
Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment schemeElisabeth Dequeker, Marjolijn J L Ligtenberg, Sara Vander Borght, et al.
International Journal of Molecular Sciences|November 24, 2020
Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes-Considerations for Future StudiesIris B A W Te Paske, Marjolijn J L Ligtenberg, Nicoline Hoogerbrugge, et al.
Cancer Letters|September 9, 2023
PARPing up the right tree; an overview of PARP inhibitors for metastatic castration-resistant prostate cancerPeter H J Slootbeek, Joanneke K Overbeek, Marjolijn J L Ligtenberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2010
A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspiratesOlga C J Schuurbiers, Monika G Looijen-Salamon, Marjolijn J L Ligtenberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2003
Dietary factors and microsatellite instability in sporadic colon carcinomasBrenda Diergaarde, Hanneke Braam, Goos N P van Muijen, et al.
Human Mutation|September 26, 2019
Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?Cleo Keppens, Véronique Tack, Kelly Dufraing, et al.
The Journal of Molecular Diagnostics : JMD|March 18, 2014
Higher quality of molecular testing, an unfulfilled priority: Results from external quality assessment for KRAS mutation testing in colorectal cancerLien Tembuyser, Marjolijn J L Ligtenberg, Nicola Normanno, et al.
Virchows Archiv : an International Journal of Pathology|November 18, 2015
RAS testing in metastatic colorectal cancer: advances in EuropeJ Han J M Van Krieken, Etienne Rouleau, Marjolijn J L Ligtenberg, et al.
Pageof 15